High-level committee's interim stay issued on Uttarakhand's order to suspend Patanjali drug licenses.
An interim stay was issued on Uttarakhand's order to suspend the manufacturing licenses of 14 Patanjali drugs, following a preliminary inquiry report by a high-level committee. The committee determined that the suspension order was "illegal" and had not been passed correctly. Patanjali Ayurved Ltd and Divya Pharmacy had challenged the suspension order issued by the Uttarakhand state licensing authority.
May 17, 2024
4 Articles